The Bulletin

PR Newswire

Final Results of Bioavailability Study of Phebra's Oral Arsenic Capsule for Acute Promyelocytic Leukaemia (APL) Confirm Bioequivalence of Oral and IV Formulations

  • Written by PR Newswire

SYDNEY, May 14, 2021 /PRNewswire/ -- Australian pharmaceutical group Phebra ('Company') congratulates the Australasian Leukaemia and Lymphoma Group (ALLG) on the release of their abstract EP433 at the virtual European Hematology Association (EHA) 2021 Conference.

The abstract builds on the initial bioequivalence data from the first phase of the...

Writers Wanted



News Co Media

Content & Technology Connecting Global Audiences

More Information - Less Opinion